• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 S. cerevisiae 宿主细胞的细胞内区室化特征,增强脂包膜病毒样颗粒的初步纯化。

Exploiting the intracellular compartmentalization characteristics of the S. cerevisiae host cell for enhancing primary purification of lipid-envelope virus-like particles.

机构信息

Dept. of Biochemical Engineering, Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London WC1E 7JE, U.K.

出版信息

Biotechnol Prog. 2010 Jan-Feb;26(1):26-33. doi: 10.1002/btpr.307.

DOI:10.1002/btpr.307
PMID:19856403
Abstract

This article demonstrates how the intracellular compartmentalization of the S. cerevisiae host cell can be exploited to impart selectivity during the primary purification of lipid-envelope virus-like particles (VLPs). The hepatitis B surface antigen (HBsAg) was used as the VLP model in this study. Expressed HBsAg remain localized on the endoplasmic reticulum and the recovery process involves treating cell homogenate with a detergent for HBsAg liberation. In our proposed strategy, a centrifugation step is introduced immediately following cell disruption but prior to the addition of detergent to allow the elimination of bulk cytosolic contaminants in the supernatant, achieving approximately 70% reduction of contaminating yeast proteins, lipids, and nucleic acids. Recovery and subsequent treatment of the solids fraction with detergent then releases the HBsAg into a significantly enriched product stream with a yield of approximately 80%. The selectivity of this approach is further enhanced by operating under moderate homogenization pressure conditions ( approximately 400 bar). Observed improvements in the recovery of active HBsAg and reduction of contaminating host lipids were attributed to the low-shear conditions experienced by the HBsAg product and reduced cell fragmentation, which led to lower coextraction of lipids during the detergent step. As a result of the cleaner process stream, the level of product capture during the loading stage of a downstream hydrophobic interaction chromatography stage increased by two-fold leading to a concomitant increase in the chromatography step yield. The lower level of exposure to contaminants is also expected to improve column integrity and lifespan.

摘要

本文展示了如何利用酿酒酵母细胞的细胞内区室化来赋予脂质包膜病毒样颗粒(VLPs)在初级纯化过程中的选择性。在本研究中,乙型肝炎表面抗原(HBsAg)被用作 VLP 模型。表达的 HBsAg 仍然定位于内质网上,回收过程涉及用去污剂处理细胞匀浆以释放 HBsAg。在我们提出的策略中,在细胞破碎后但在添加去污剂之前立即引入离心步骤,以允许上清液中去除大量胞质污染物,使污染的酵母蛋白、脂质和核酸减少约 70%。然后,用去污剂回收和随后处理固体部分将 HBsAg 释放到一个显著富集的产物流中,收率约为 80%。这种方法的选择性通过在适度的匀浆压力条件(约 400 巴)下操作进一步增强。观察到活性 HBsAg 的回收率提高和污染宿主脂质减少归因于 HBsAg 产物经历的低剪切条件和细胞破碎减少,这导致在去污剂步骤中脂质的共提取减少。由于处理后的流更加清洁,在下游疏水性相互作用色谱阶段的加载阶段的产物捕获水平增加了一倍,导致色谱步骤的收率相应增加。接触污染物的水平降低也有望提高柱的完整性和寿命。

相似文献

1
Exploiting the intracellular compartmentalization characteristics of the S. cerevisiae host cell for enhancing primary purification of lipid-envelope virus-like particles.利用 S. cerevisiae 宿主细胞的细胞内区室化特征,增强脂包膜病毒样颗粒的初步纯化。
Biotechnol Prog. 2010 Jan-Feb;26(1):26-33. doi: 10.1002/btpr.307.
2
Study of detergent-mediated liberation of hepatitis B virus-like particles from S. cerevisiae homogenate: identifying a framework for the design of future-generation lipoprotein vaccine processes.洗涤剂介导的从酿酒酵母匀浆中释放乙型肝炎病毒样颗粒的研究:确定下一代脂蛋白疫苗生产工艺设计的框架。
Biotechnol Prog. 2008 May-Jun;24(3):623-31. doi: 10.1021/bp070472i. Epub 2008 Apr 23.
3
Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties.从重组毕赤酵母中纯化乙型肝炎表面抗原病毒样颗粒及其体内免疫原性分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Dec 1;940:104-11. doi: 10.1016/j.jchromb.2013.09.030. Epub 2013 Sep 27.
4
Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris.登革2型病毒包膜蛋白与乙型肝炎表面抗原融合在毕赤酵母中的表达与纯化
Protein Expr Purif. 2001 Oct;23(1):84-96. doi: 10.1006/prep.2001.1474.
5
Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.从酿酒酵母中高效快速纯化携带药物和基因的生物纳米胶囊——乙型肝炎病毒表面抗原L颗粒。
Protein Expr Purif. 2011 Aug;78(2):149-55. doi: 10.1016/j.pep.2011.04.008. Epub 2011 Apr 14.
6
Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form.乙型肝炎表面抗原(HBsAg)在植物细胞培养中的表达:分批培养中抗原积累的动力学及其细胞内形式。
Biotechnol Bioeng. 2002 Dec 30;80(7):812-22. doi: 10.1002/bit.10444.
7
Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.用嵌合乙型肝炎病毒样颗粒进行免疫接种以诱导潜在的抗丙型肝炎病毒中和抗体。
Antivir Ther. 2007;12(4):477-87.
8
A microscale yeast cell disruption technique for integrated process development strategies.一种用于集成工艺开发策略的微尺度酵母细胞破碎技术。
Biotechnol Prog. 2008 May-Jun;24(3):606-14. doi: 10.1021/bp070359s. Epub 2008 Apr 15.
9
A combinatorial strategy of a new monoclonal ELISA and immunoaffinity chromatography using sodium deoxycholate to increase the recovery of multimeric proteins like r-HBsAg.采用新的单克隆 ELISA 和免疫亲和层析的组合策略,使用脱氧胆酸钠来增加像 r-HBsAg 这样的多聚体蛋白的回收率。
Talanta. 2010 Apr 15;81(1-2):314-9. doi: 10.1016/j.talanta.2009.12.002. Epub 2009 Dec 16.
10
Ultrastructural analysis of hepatitis B surface antigen production in vitro.体外乙肝表面抗原产生的超微结构分析。
Lab Invest. 1982 Nov;47(5):465-70.

引用本文的文献

1
Selective extraction of recombinant membrane proteins from Hansenula polymorpha by pulsed electric field and lytic enzyme pretreatment.脉冲电场和溶酶预处理从汉逊德巴利酵母中选择性提取重组膜蛋白。
Microb Cell Fact. 2023 Dec 8;22(1):251. doi: 10.1186/s12934-023-02259-z.
2
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity.探索基于 FeLV-Gag 的 VLPs 作为新型疫苗平台:生产与免疫原性分析。
Int J Mol Sci. 2023 May 19;24(10):9025. doi: 10.3390/ijms24109025.
3
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.
基于酵母的病毒样颗粒作为疫苗开发与递送的新兴平台
Vaccines (Basel). 2023 Feb 18;11(2):479. doi: 10.3390/vaccines11020479.
4
Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development.病毒样颗粒作为一种高效的疫苗平台:多样化的目标和生产系统以及临床开发的进展。
Vaccine. 2012 Dec 17;31(1):58-83. doi: 10.1016/j.vaccine.2012.10.083. Epub 2012 Nov 6.
5
Plant-derived virus-like particles as vaccines.植物源病毒样颗粒疫苗。
Hum Vaccin Immunother. 2013 Jan;9(1):26-49. doi: 10.4161/hv.22218. Epub 2012 Sep 20.